SRC and cancer: Given the oncogenic potential of Src, it is reasonable to speculate that, as occurs under physiological conditions of Golgi fragmentation in G2, cancer cells with a fragmented Golgi complex continuously turn on the Golgi-dependent signalling pathway required for Src activation thus stimulating uncontrolled cell proliferation and favouring genomic instability.